A Study Of Avelumab In Combination With Axitinib In Advanced HCC (VEGF Liver 100)

Clinical trial NCT03289533 · COMPLETED

Trial details

NCT number: NCT03289533
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Hepatocellular

Start date: 2017-09-08
Primary completion: 2019-08-27
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.